Nina Resetkova

Dr. Nina Resetkova (she/her) is a Reproductive Endocrinologist at Everleap Fertility. Dr. Resetkova is double board-certified in Obstetrics and Gynecology/Reproductive Endocrinology and Infertility. She specializes in all aspects of fertility care.

Dr. Nina Resetkova was born in Slovakia, a small country in Eastern Europe. She immigrated with her family at a young age to Toronto, Canada, where she completed her primary and secondary education. She graduated with a Bachelor of Science in Biochemistry and a Minor in Management from McGill University in Montreal, Canada.

She then moved to the United Sates in pursuit of a combined MD, MBA degree. She earned her medical degree from Texas Tech University Health Sciences Center School of Medicine. While completing her medical training, she simultaneously obtained a Masters in Business Administration, specializing in Health Organization Management. She chose a competitive Obstetrics and Gynecology residency training program at the world renowned Johns Hopkins Hospital in Baltimore, MD. During her residency, she served on the ethics and quality improvement committees. She was actively involved in leadership on the Johns Hopkins House Staff Council, and served as the elected Vice Chair of Communications.

Dr. Resetkova is a Fellow of the American College of Obstetricians and Gynecologists. She is a member of the American Society of Reproductive Medicine, as well as the New England Fertility Society, where she served in an executive role.  Her research interests include the application of cost effectiveness studies in medicine. Her work pertaining to cost effectiveness of preimplantation genetic screening (PGS) for patients with recurrent pregnancy loss was selected for a prize oral presentation at the 2013 American Society of Reproductive Medicine annual conference. She completed a research fellowship studying the RNA profile of the developing embryo at the Harvard Department of Stem Cell and Reproductive Biology.

Dr. Resetkova sees a wide spectrum of fertility patients, including those who would like to explore fertility options and fertility preservation. She has a special interest in caring for the LGBTQ patient population. Her novel research examining transgender fertility preservation outcomes has been presented at national meetings.

She enjoys spending time with her family, long walks with her dog and playing chess. She is always working on improving her yoga practice.

Publications

1. Shah JS, Modest AM, Hacker MR, Resetkova N, Dodge LE. Association of Early Beta Human Chorionic Gonadotropin With Ischemic Placental Disease in Singleton Pregnancies After In Vitro Fertilization. Cureus. 2022 Aug; 14(8):e28117. PMID: 36134080; PMCID: PMC9481264

2. Thornton KL, Resetkova N. Pursuit of pregnancy by lesbian women: an opportunity to create best practice. F S Rep. 2021 Sep; 2(3):263-264. PMID: 34553146; PMCID: PMC8441552

3. Leung A, Sakkas D, Pang S, Thornton K, Resetkova N. Assisted reproductive technology outcomes in female-to-male transgender patients compared with cisgender patients: a new frontier in reproductive medicine. Fertil Steril. 2019 11; 112(5):858-865. PMID: 31594633

4. Groff AF, Resetkova N, DiDomenico F, Sakkas D, Penzias A, Rinn JL, Eggan K. RNA-seq as a tool for evaluating human embryo competence. Genome Res. 2019 10; 29(10):1705-1718. PMID: 31548358; PMCID: PMC6771404

5. Modest AM, Johnson KM, Karumanchi SA, Resetkova N, Young BC, Fox MP, Wise LA, Hacker MR. Risk of ischemic placental disease is increased following in vitro fertilization with oocyte donation: a retrospective cohort study. J Assist Reprod Genet. 2019 Sep; 36(9):1917-1926. PMID: 31359234; PMCID: PMC6730979

6. Johnson KM, Hacker MR, Resetkova N, O'Brien B, Modest AM. Risk of ischemic placental disease in fresh and frozen embryo transfer cycles. Fertil Steril. 2019 04; 111(4):714-721. PMID: 30826115; PMCID: PMC6443502

7. Murphy LA, Seidler EA, Vaughan DA, Resetkova N, Penzias AS, Toth TL, Thornton KL, Sakkas D. To test or not to test? A framework for counselling patients on preimplantation genetic testing for aneuploidy (PGT-A). Hum Reprod. 2019 02 01; 34(2):268-275. PMID: 30500907

8. Vaughan DA, Leung A, Resetkova N, Ruthazer R, Penzias AS, Sakkas D, Alper MM. How many oocytes are optimal to achieve multiple live births with one stimulation cycle? The one-and-done approach. Fertil Steril. 2017 02; 107(2):397-404.e3. PMID: 27916206

9. O'Brien K, Shainker SA, Modest AM, Spiel MH, Resetkova N, Shah N, Hacker MR. Cost Analysis of Following Up Incomplete Low-Risk Fetal Anatomy Ultrasounds. Birth. 2017 03; 44(1):35-40. PMID: 27862256

10. Selter JH, Christianson MS, Washington CI, Resetkova N, Kolp L. Hydronephrosis: A Rare Presentation of Uterine Didelphys with Obstructed Hemivagina and Ipsilateral Renal Anomaly. J Pediatr Adolesc Gynecol. 2016 Jun; 29(3):e53-5. PMID: 26772967

11. Resetkova N, Hayashi M, Kolp LA, Christianson MS. Fertility Preservation for Prepubertal Girls: Update and Current Challenges. Curr Obstet Gynecol Rep. 2013 Dec 01; 2(4):218-225. PMID: 25110617